On combination therapy of diabetes with metformin and dipeptidyl peptidase IV inhibitors

被引：12
|
作者：
Hinke, SA
McIntosh, CHS
Hoffmann, T
Kuhn-Wache, K
Wagner, L
Bär, J
Manhart, S
Wermann, M
Pederson, RA
Demuth, HU
机构：
[1] Probiodrug AG, D-06120 Halle Saale, Germany
[2] Univ British Columbia, Dept Physiol, Vancouver, BC V5Z 1M9, Canada
来源：
DIABETES CARE | 2002年 / 25卷 / 08期
关键词：
D O I：
10.2337/diacare.25.8.1490-b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1490 / 1491
页数：2
相关论文
共 50 条
  • [21] Recent patents of dipeptidyl peptidase IV inhibitors
    Mendieta, Laura
    Tarrago, Teresa
    Giralt, Ernest
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (11) : 1693 - 1741
  • [22] Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus
    Langley, Alissa K.
    Suffoletta, Terri J.
    Jennings, Heath R.
    PHARMACOTHERAPY, 2007, 27 (08): : 1163 - 1180
  • [23] Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
    Janardhan, Sridhara
    Sastry, G. Narahari
    CURRENT DRUG TARGETS, 2014, 15 (06) : 600 - 621
  • [24] Therapeutic potential of dipeptidyl peptidase-IV inhibitors in patients with diabetes mellitus
    Moore, Kevin B.
    Saudek, Christopher D.
    AMERICAN JOURNAL OF THERAPEUTICS, 2008, 15 (05) : 484 - 491
  • [25] Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes
    Drucker, DJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (01) : 87 - 100
  • [26] Dose adjustment of metformin and dipeptidyl-peptidase IV inhibitors in diabetic patients with renal dysfunction
    Melzer-Cohen, Cheli
    Karasik, Avraham
    Leuschner, Philipp J.
    Azuri, Joseph
    Shalev, Varda
    Chodick, Gabriel
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1849 - 1854
  • [27] Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin
    Skandalis, K.
    Spirova, M.
    Gaitanis, G.
    Tsartsarakis, A.
    Bassukas, I. D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (02) : 249 - 253
  • [28] Effects of addition of a dipeptidyl peptidase IV inhibitor to metformin on sirolimus-induced diabetes mellitus
    Jin, Long
    Lim, Sun Woo
    Jin, Jian
    Chung, Byung Ha
    Yang, Chul Woo
    TRANSPLANTATION, 2016, 100 (07) : S464 - S464
  • [29] Effects of addition of a dipeptidyl peptidase IV inhibitor to metformin on sirolimus-induced diabetes mellitus
    Jin, Long
    Lim, Sun Woo
    Jin, Jian
    Chung, Byung Ha
    Yang, Chul Woo
    TRANSLATIONAL RESEARCH, 2016, 174 : 122 - 139
  • [30] Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes
    Augustyns, K
    Van der Veken, P
    Senten, K
    Haemers, A
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (04) : 499 - 510
12345